Ethics Transparency

Transparency Disclosures

Disclosure of Grants
Outside the U.S.

Disclosure of Grants
Outside the U.S.
Transparency Disclosures

Disclosure of grants to patient organizations has been mandatory in Europe since March 2009. However, in Europe, the Middle East and Africa, we voluntarily began disclosing financial support to patient organizations in 2008, and in Canada in 2009.

In October 2009, our company in Europe, the Middle East, Africa and Canada, also began to disclose grants to other third-party organizations such as medical societies and scientific organizations. The information disclosed includes the organizations, the amounts received, the dates of payment and the projects for which the money was used. Disclosures include all donations and charitable contributions, grants and membership fees to professional societies or other medical or scientific organizations. We were a member of the working group to develop the European Federation of Pharmaceutical Industries and Associations (EFPIA) Code of Practice on Relationships between the Pharmaceutical Industry and Patient Organisations, which became effective on July 1, 2008.

We update grants to medical, scientific and patient organizations annually for ex-U.S. jurisdictions.

Disclosures Outside the United States